To further extend the structure–activity relationships (SARs) of thepreviously published ubiquitin-specific protease 7 (USP-7) inhibi-tor STIRUR-41, a small library of 5-aminopyrazoles 1a–d and 2a–dis designed and synthesized. The chemical identity of the desiredstructure is confirmed by nuclear magnetic resonance and singlecrystal X-ray diffraction analyses. All novel derivatives are testedas potential USP-7 inhibitors and compounds 1a–d block enzymeactivity in a dose-dependent manner and with lower IC 50 valuescompared to the lead compound STIRUR-41. Notably, 1d, bearinga meta-trifluoromethylphenyl group linked to the carbamate moi-ety, proved to be the most active candidate. Conversely, com-pounds belonging to series 2, which possess greater sterichindrance, exhibit no activity. The most effective compoundsof series 1 are noncytotoxic across a panel of tumor and normalcell lines at 10 μM concentration. For the most active compound1d, a parallel artificial membrane permeability assay is also per-formed, as well as docking and molecular dynamics simulations.
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation / Lusardi, Matteo; Morretta, Elva; Spallarossa, Andrea; Chiara Monti, Maria; Rosano, Camillo; Iervasi, Erika; Ponassi, Marco; Mori, Matteo; Meneghetti, Fiorella; Brullo, Chiara. - In: CHEMMEDCHEM. - ISSN 1860-7179. - (2025). [10.1002/cmdc.202500185]
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
Morretta, Elva;Chiara Monti, Maria;
2025
Abstract
To further extend the structure–activity relationships (SARs) of thepreviously published ubiquitin-specific protease 7 (USP-7) inhibi-tor STIRUR-41, a small library of 5-aminopyrazoles 1a–d and 2a–dis designed and synthesized. The chemical identity of the desiredstructure is confirmed by nuclear magnetic resonance and singlecrystal X-ray diffraction analyses. All novel derivatives are testedas potential USP-7 inhibitors and compounds 1a–d block enzymeactivity in a dose-dependent manner and with lower IC 50 valuescompared to the lead compound STIRUR-41. Notably, 1d, bearinga meta-trifluoromethylphenyl group linked to the carbamate moi-ety, proved to be the most active candidate. Conversely, com-pounds belonging to series 2, which possess greater sterichindrance, exhibit no activity. The most effective compoundsof series 1 are noncytotoxic across a panel of tumor and normalcell lines at 10 μM concentration. For the most active compound1d, a parallel artificial membrane permeability assay is also per-formed, as well as docking and molecular dynamics simulations.| File | Dimensione | Formato | |
|---|---|---|---|
|
144_ChemMedChem_2025.pdf
non disponibili
Licenza:
Copyright dell'editore
Dimensione
1.28 MB
Formato
Adobe PDF
|
1.28 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


